Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth

Abstract : DNA methylation is a fundamental feature of genomes and is a candidate for pharmacological manipulation that might have important therapeutic advantage. Thus, DNA methyltransferases (DNMTs) appear to be ideal targets for drug intervention. By focusing on interactions existing between DNMT3A and DNMT3A-binding protein (D3A-BP), our work identifies the DNMT3A/ISGF3γ interaction such as a biomarker whose the presence level is associated with a poor survival prognosis and with a poor prognosis of response to the conventional chemotherapeutic treatment of glioblastoma multiforme (radiation plus temozolomide). Our data also demonstrates that the disruption of DNMT3A/ISGF3γ interactions increases the efficiency of chemotherapeutic treatment on established tumors in mice. Thus, our data opens a promising and innovative alternative to the development of specific DNMT inhibitors.
Document type :
Journal articles
Complete list of metadatas

Cited literature [35 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01414173
Contributor : Elizabeth Bernardo <>
Submitted on : Monday, December 12, 2016 - 10:35:43 AM
Last modification on : Tuesday, August 13, 2019 - 3:28:03 PM
Long-term archiving on : Tuesday, March 28, 2017 - 12:54:28 AM

File

2016Art3Eq9.pdf
Files produced by the author(s)

Identifiers

Collections

Citation

Mathilde Cheray, Romain Pacaud, Arulraj Nadaradjane, Lisa Oliver, François Vallette, et al.. Specific Inhibition of DNMT3A/ISGF3γ Interaction Increases the Temozolomide Efficiency to Reduce Tumor Growth. Theranostics, Ivyspring International Publisher, 2016, 6, pp.1988 - 1999. ⟨10.7150/thno.9150⟩. ⟨inserm-01414173⟩

Share

Metrics

Record views

238

Files downloads

265